- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
105 Acute Myeloid Leukemia Trials Near You
Power is an online platform that helps thousands of Acute Myeloid Leukemia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerCPX-351 + Gilteritinib for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
1186 Participants Needed
Trial Details
Key Eligibility Criteria
670 Participants Needed
Venetoclax + Chemotherapy for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
98 Participants Needed
Iomab-B + HCT for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
153 Participants Needed
Bortezomib + Sorafenib for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
1645 Participants Needed
Ziftomenib for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
70 Participants Needed
Novel Therapies for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
335 Participants Needed
Natural Killer Cell Therapy for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
20 Participants Needed
Trial Details
Key Eligibility Criteria
125 Participants Needed
DSP-5336 for Leukemia
Trial Details
Key Eligibility Criteria
362 Participants Needed
Tuspetinib for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
240 Participants Needed
Trial Details
Key Eligibility Criteria
64 Participants Needed
BSB-1001 for Blood Cancers
Trial Details
Key Eligibility Criteria
38 Participants Needed
SAR443579 + Other Agents for Blood Cancers
Trial Details
Key Eligibility Criteria
18 Participants Needed
NK Cell Infusions for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
30 Participants Needed
Venetoclax + Azacitidine for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
172 Participants Needed
ASTX727 + Venetoclax for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
101 Participants Needed
Emavusertib (+ Venetoclax) for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
366 Participants Needed
Targeted Therapies for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
2000 Participants Needed
Azacitidine + Gemtuzumab for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
133 Participants Needed
Why Other Patients Applied
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Eganelisib + Cytarabine for AML
Trial Details
Key Eligibility Criteria
125 Participants Needed
SNDX-5613 + Chemotherapy for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
28 Participants Needed
Ziftomenib Combinations for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
212 Participants Needed
Treosulfan for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
36 Participants Needed
Trial Details
Key Eligibility Criteria
178 Participants Needed
Gemtuzumab + Midostaurin for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
18 Participants Needed
SGR-2921 for Leukemia and Preleukemia
Trial Details
Key Eligibility Criteria
50 Participants Needed
Navtemadlin + Decitabine for Acute Myeloid Leukemia
Trial Details
Key Eligibility Criteria
58 Participants Needed
Trial Details
Key Eligibility Criteria
153 Participants Needed
Trial Details
Key Eligibility Criteria
15 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Acute Myeloid Leukemia clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Acute Myeloid Leukemia clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Acute Myeloid Leukemia trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Acute Myeloid Leukemia is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Acute Myeloid Leukemia medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Acute Myeloid Leukemia clinical trials?
Most recently, we added Bleximenib + Venetoclax + Azacitidine for Acute Myeloid Leukemia, Ziftomenib for Acute Myeloid Leukemia and AUTX-703 for Acute Myeloid Leukemia and Myelodysplastic Syndrome to the Power online platform.